J. Uriach and Company   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Palau-Solita Spain (2003)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2003
NCT00162799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

J. Uriach and Company | Uriach Consumer Healthcare